Last 46 quarters of trend data · Real Estate · REIT - Healthcare Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
EV/EBITDA has expanded 25.8% YoY to 10.7x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 115.29 | — | — | 13.89 | 18.74 | 18.22 | — | 12.76 | 59.04 | 6.40 | 2.54 | 14.02 | — |
| — | — | — | +8.9% | -68.3% | +184.7% | — | -9.0% | — | +80.2% | -86.4% | +8.2% | — | |
| P/S Ratio | 0.68 | 2.78 | 0.61 | 0.85 | 0.74 | 0.95 | 0.87 | 0.82 | 1.10 | 0.83 | 0.82 | 0.82 | 0.86 |
| — | +191.7% | -29.7% | +3.4% | -33.2% | +15.0% | +5.7% | -0.7% | +29.2% | +5.1% | -24.6% | -50.7% | -54.5% | |
| P/B Ratio | 0.17 | 0.89 | 0.18 | 0.22 | 0.19 | 0.23 | 0.21 | 0.19 | 0.24 | 0.19 | 0.19 | 0.19 | 0.19 |
| — | +286.4% | -14.3% | +13.2% | -22.7% | +24.3% | +10.4% | +1.2% | +25.5% | +10.5% | -17.7% | -41.8% | -46.6% | |
| P/FCF | — | 1.22 | — | — | — | 1.51 | 1.89 | 2.33 | 2.54 | 2.22 | 1.88 | 1.99 | 1.90 |
| — | -19.6% | — | — | — | -31.9% | +0.7% | +17.0% | +34.1% | — | — | — | — | |
| EV / EBITDA | 8.35 | 10.67 | 8.59 | 8.51 | 9.28 | 8.48 | 8.20 | 7.95 | 8.37 | 6.93 | 4.98 | 8.02 | 6.05 |
| — | +25.8% | +4.8% | +7.0% | +10.9% | +22.4% | +64.7% | -0.9% | +38.4% | -13.6% | -8.9% | -9.9% | -10.2% | |
| EV / EBIT | 22.68 | — | 23.64 | 18.43 | 17.93 | 17.99 | 36.69 | 20.20 | 25.32 | 15.23 | 18.75 | 15.28 | 20.80 |
| — | — | -35.6% | -8.8% | -29.2% | +18.1% | +95.7% | +32.2% | +21.7% | -19.5% | -13.0% | -41.7% | -4.1% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Global Medical REIT Inc.'s operating margin was 30.7% in Q3 2025, up 8.7 pp QoQ and up 5.2 pp YoY. The trailing four-quarter average of 24.7% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin contracted 45.4% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.9% | 42.7% | 78.3% | 78.1% | 79.4% | 78.2% | 78.9% | 78.9% | 81.5% | 79.6% | 100.0% | 79.2% | 99.7% |
| — | -45.4% | -0.7% | -1.1% | -2.6% | -1.7% | -21.1% | -0.3% | -18.3% | -1.9% | +0.3% | -4.7% | -0.3% | |
| Operating Margin | 23.6% | 30.7% | 22.0% | 27.6% | 18.3% | 25.5% | 24.5% | 26.1% | 25.4% | — | 64.2% | 27.6% | 55.3% |
| — | +20.6% | -10.2% | +5.9% | -27.9% | — | -61.8% | -5.4% | -54.0% | — | -7.0% | -3.6% | -6.7% | |
| Net Margin | 4.8% | -11.2% | 1.7% | 10.3% | 8.1% | 9.5% | -4.9% | 6.4% | 1.9% | 12.9% | 36.5% | 5.9% | 5.0% |
| — | -218.0% | +135.0% | +60.4% | +332.8% | -26.6% | -113.5% | +9.2% | -62.8% | -43.1% | +233.4% | -54.5% | -71.0% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 1.1% | -0.9% | 0.1% | 0.7% | 0.5% | 0.6% | -0.3% | 0.4% | 0.1% | 0.7% | 2.1% | 0.3% | 0.3% |
| — | -255.3% | +142.8% | +74.0% | +408.1% | -21.2% | -113.8% | +12.2% | -64.2% | -41.3% | +268.7% | -47.8% | -66.5% | |
| ROA | 0.5% | -0.4% | 0.1% | 0.3% | 0.2% | 0.3% | -0.1% | 0.2% | 0.0% | 0.4% | 1.0% | 0.2% | 0.1% |
| — | -235.3% | +137.7% | +58.6% | +372.9% | -25.4% | -113.7% | +15.3% | -63.2% | -39.9% | +253.4% | -52.3% | -68.9% | |
| ROIC | 2.0% | 0.8% | 0.5% | 0.6% | 0.4% | 0.5% | 0.5% | 0.6% | 0.5% | — | 1.4% | 0.6% | 1.1% |
| — | +38.8% | -2.4% | +5.2% | -21.3% | — | -61.9% | -0.7% | -54.4% | — | -1.1% | +0.8% | -0.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Global Medical REIT Inc.'s Debt/EBITDA ratio is 26.5x, down from 30.7x last quarter — elevated, raising questions about debt serviceability. The current ratio has improved 1812.9% YoY to 0.53x, strengthening the short-term liquidity position. Debt/Equity has risen for 9 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.18 | 1.44 | 1.38 | 1.29 | 1.18 | 1.13 | 1.08 | 1.06 | 1.02 | 1.00 | 1.00 | 1.12 | 1.09 |
| — | +27.1% | +28.0% | +21.9% | +15.8% | +13.8% | +8.5% | -5.5% | -5.9% | -6.0% | -3.6% | +22.0% | +19.4% | |
| Debt / EBITDA | 7.36 | 26.52 | 30.74 | 29.32 | 32.38 | 28.40 | 27.75 | 26.96 | 27.16 | 23.93 | 17.23 | 28.21 | 20.67 |
| — | -6.6% | +10.7% | +8.8% | +19.2% | +18.7% | +61.1% | -4.4% | +31.4% | -15.8% | -6.6% | +5.3% | +6.0% | |
| Current Ratio | 0.03 | 0.53 | 1.32 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | — | — | — | 0.05 |
| — | +1812.9% | +4751.3% | -8.7% | +11.5% | — | — | — | -49.1% | — | — | — | -1.4% | |
| Quick Ratio | 0.03 | 0.53 | 1.32 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | — | — | — | 0.05 |
| — | +1812.9% | +4751.3% | -8.7% | +11.5% | — | — | — | -49.1% | — | — | — | -1.4% | |
| Interest Coverage | 1.14 | 1.08 | 1.04 | 1.33 | 0.85 | 1.20 | 1.20 | 1.33 | 1.20 | — | 2.76 | 1.21 | 2.49 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 46 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying GMRE stock.
Global Medical REIT Inc.'s current P/E is 115.3x. The average P/E over the last 2 quarters is 16.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Global Medical REIT Inc.'s current operating margin is 23.6%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Global Medical REIT Inc.'s business trajectory between earnings reports.